In most of his Receptor studies, his work intersects topics such as Semaphorin. Many of his studies involve connections with topics such as Receptor and Semaphorin. His Angiogenin research extends to the thematically linked field of Cancer research. Michael Klagsbrun performs multidisciplinary study in Angiogenin and Angiogenesis in his work. In his study, Michael Klagsbrun carries out multidisciplinary Angiogenesis and Neovascularization research. He integrates Neovascularization with Vascular endothelial growth factor in his research. His study on Vascular endothelial growth factor is mostly dedicated to connecting different topics, such as VEGF receptors. Much of his study explores VEGF receptors relationship to Cancer research. He integrates Genetics with Immunology in his research.
Many of his studies on Biochemistry apply to Heparan sulfate as well. In his articles, he combines various disciplines, including Cell biology and Immunology. He performs integrative Immunology and Cell biology research in his work. As part of his studies on Receptor, he often connects relevant areas like Autocrine signalling. His study brings together the fields of Receptor and Autocrine signalling. He performs multidisciplinary study in Molecular biology and Cell culture in his work. In his papers, Michael Klagsbrun integrates diverse fields, such as Cell culture and Molecular biology. Angiogenesis is often connected to Cancer research in his work. His Cancer research study typically links adjacent topics like Angiogenesis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor.
Avner Yayon;Michael Klagsbrun;Jeffrey D. Esko;Philip Leder.
Neuropilin-1 Is Expressed by Endothelial and Tumor Cells as an Isoform-Specific Receptor for Vascular Endothelial Growth Factor
Shay Soker;Seiji Takashima;Hua Quan Miao;Gera Neufeld.
A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF.
S Higashiyama;JA Abraham;J Miller;JC Fiddes.
Regulators of angiogenesis.
M Klagsbrun;P A D'Amore.
Annual Review of Physiology (1991)
Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix
Israel Vlodavsky;Judah Folkman;Robert Sullivan;Rafael Fridman.
Proceedings of the National Academy of Sciences of the United States of America (1987)
Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin-Sepharose
Peter V. Hauschka;Athanasios E. Mavrakos;Mark D. Iafrati;Susan E. Doleman.
Journal of Biological Chemistry (1986)
Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor
Y Shing;J Folkman;R Sullivan;C Butterfield.
A heparin-binding angiogenic protein--basic fibroblast growth factor--is stored within basement membrane.
J Folkman;M Klagsbrun;J Sasse;M Wadzinski.
American Journal of Pathology (1988)
Heparin-binding EGF-like growth factor gene is induced in the mouse uterus temporally by the blastocyst solely at the site of its apposition: a possible ligand for interaction with blastocyst EGF-receptor in implantation
S. K. Das;Xiao-Ning Wang;B. C. Paria;D. Damm.
Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules.
Pnina Bashkin;Susan Doctrow;Michael Klagsbrun;Carl Magnus Svahn.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: